Apr 15, 2021 / 09:00PM GMT
Operator
Good day and thank you for standing by. Welcome to the Precision Regains Global Commercial Rights to CAR T Programs Conference Call. (Operator Instructions). Please be advised that today's conference is being recorded. (Operator Instructions). I would now like to hand the conference over to your speaker today, Alex Kelly, Interim Chief Financial Officer and Corporate Affairs Officer. Please go ahead.
Alex Kelly - Precision BioSciences - Interim CFO & Corporate Affairs Officer
Thank you, Gigi. And good afternoon, everyone, and welcome to our webcast to discuss our agreement with Servier to reacquire rights to our CAR T programs.
Before we begin, I would like to remind you that the statements we make today on this webcast do not relate to matters of historical fact or future -- [or our] future expectations and forward-looking statements.
Our forward-looking statements are within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other
Precision BioSciences Inc Reacquires Global Rights to its Allogeneic CAR T Programs- Conference Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot